| - GRCh37:
- Chr1:161275939-161275940
- GRCh38:
- Chr1:161306149-161306150
| MPZ | L202fs | Roussy-Lévy syndrome | Uncertain significance (Jul 2, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161276553-161276554
- GRCh38:
- Chr1:161306763-161306764
| MPZ | N131fs | Roussy-Lévy syndrome | Likely pathogenic (Mar 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161275306
- GRCh38:
- Chr1:161305516
| MPZ | | Neuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Conflicting interpretations of pathogenicity (Aug 24, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161275297
- GRCh38:
- Chr1:161305507
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161274914
- GRCh38:
- Chr1:161305124
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161274763
- GRCh38:
- Chr1:161304973
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161277098
- GRCh38:
- Chr1:161307308
| MPZ | I62V | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161275231
- GRCh38:
- Chr1:161305441
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161275144
- GRCh38:
- Chr1:161305354
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161275564
- GRCh38:
- Chr1:161305774
| MPZ | | Roussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161275325
- GRCh38:
- Chr1:161305535
| MPZ | | Roussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161276502
- GRCh38:
- Chr1:161306712
| MPZ | E148D | Roussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161277109
- GRCh38:
- Chr1:161307319
| MPZ | V58D | Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome | Conflicting interpretations of pathogenicity (Mar 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:15168570
- GRCh38:
- Chr17:15265253
| PMP22 | | Guillain-Barre syndrome, familial, Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease, type IA, Roussy-Lévy syndrome, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 1E
| Uncertain significance (Dec 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:15134355
- GRCh38:
- Chr17:15231038
| PMP22 | H121R | not provided | Uncertain significance (Feb 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:15142852
- GRCh38:
- Chr17:15239535
| PMP22 | C85W | Guillain-Barre syndrome, familial, Roussy-Lévy syndrome, Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease, type IA, Dejerine-Sottas disease, not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease, type I
| Uncertain significance (Jun 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276518
- GRCh38:
- Chr1:161306728
| MPZ | T143M | Neuropathy, congenital hypomyelinating, 2, Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome | Uncertain significance (Aug 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276549
- GRCh38:
- Chr1:161306759
| MPZ | P133T | Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease, type I | Pathogenic/Likely pathogenic (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:15134239
- GRCh38:
- Chr17:15230922
| PMP22 | E160K | Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1E, Guillain-Barre syndrome, familial, Roussy-Lévy syndrome, Dejerine-Sottas disease, Charcot-Marie-Tooth disease, type IA, Hereditary liability to pressure palsies | Uncertain significance (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:15134321
- GRCh38:
- Chr17:15231004
| PMP22 | | Guillain-Barre syndrome, familial, Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease, type IA, Hereditary liability to pressure palsies, Roussy-Lévy syndrome, Dejerine-Sottas disease, not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease, type I, not specified | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161275714
- GRCh38:
- Chr1:161305924
| MPZ | S233R | Roussy-Lévy syndrome, Sensorimotor neuropathy, EMG: neuropathic changes, Limb muscle weakness, Tremor | Likely pathogenic (Jan 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:15134295
- GRCh38:
- Chr17:15230978
| PMP22 | V141G | Roussy-Lévy syndrome, Spasticity, Respiratory distress, Tongue fasciculations | Uncertain significance (Jan 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161284158
- GRCh38:
- Chr1:161314368
| MPZ, SDHC | | Paragangliomas 3, Gastrointestinal stroma tumor, not provided, Hereditary cancer-predisposing syndrome, not specified, Charcot-Marie-Tooth disease type 4E, Hereditary pheochromocytoma-paraganglioma, Roussy-Lévy syndrome, Pheochromocytoma, Paragangliomas 3, Charcot-Marie-Tooth, IntermediateCharcot-Marie-Tooth disease, type I, Paragangliomas 3, Gastrointestinal stroma tumor, Carney-Stratakis syndrome, ...see more | Benign (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:15162516
- GRCh38:
- Chr17:15259199
| PMP22 | | Guillain-Barre syndrome, familial, Roussy-Lévy syndrome, Dejerine-Sottas disease, Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease, type IA, not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease, Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease, type I ...see more | Benign/Likely benign (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161279744
- GRCh38:
- Chr1:161309954
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Conflicting interpretations of pathogenicity (Jan 12, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161277205
- GRCh38:
- Chr1:161307415
| MPZ | P26L | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Conflicting interpretations of pathogenicity (Apr 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161276199
- GRCh38:
- Chr1:161306409
| MPZ | | Charcot-Marie-Tooth disease, type I, not specified, Neuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome
| Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276188
- GRCh38:
- Chr1:161306398
| MPZ | L172P | Charcot-Marie-Tooth, Intermediate, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161275614
- GRCh38:
- Chr1:161305824
| MPZ | G267S | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161275471
- GRCh38:
- Chr1:161305681
| MPZ | | Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Neuropathy, congenital hypomyelinating, 2, not provided
| Conflicting interpretations of pathogenicity (Oct 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161275415
- GRCh38:
- Chr1:161305625
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161275098
- GRCh38:
- Chr1:161305308
| MPZ | | Neuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
| Benign/Likely benign (May 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161275042
- GRCh38:
- Chr1:161305252
| MPZ | | Neuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
| Benign/Likely benign (May 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161274985
- GRCh38:
- Chr1:161305195
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161274923
- GRCh38:
- Chr1:161305133
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome | Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161274905
- GRCh38:
- Chr1:161305115
| MPZ | | Neuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome
| Benign (May 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161274808
- GRCh38:
- Chr1:161305018
| MPZ | | Charcot-Marie-Tooth, Intermediate, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type I | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161274755-161274756
- GRCh38:
- Chr1:161304965-161304966
| MPZ | | Charcot-Marie-Tooth, Intermediate, not provided, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome | Benign (May 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161274712
- GRCh38:
- Chr1:161304922
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161274646
- GRCh38:
- Chr1:161304856
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161274618
- GRCh38:
- Chr1:161304828
| MPZ | | not provided, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D
| Conflicting interpretations of pathogenicity (May 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161274592
- GRCh38:
- Chr1:161304802
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161275906
- GRCh38:
- Chr1:161306116
| MPZ | G213R | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, Inborn genetic diseases, not provided, not specified, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome | Conflicting interpretations of pathogenicity (Oct 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161277149
- GRCh38:
- Chr1:161307359
| MPZ | R45W | Charcot-Marie-Tooth disease, type I, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 4E, not provided | Conflicting interpretations of pathogenicity (Oct 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161277082
- GRCh38:
- Chr1:161307292
| MPZ | R67H | Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, not specified, Neuropathy, congenital hypomyelinating, 2, Inborn genetic diseases, Roussy-Lévy syndrome, not provided, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D
| Conflicting interpretations of pathogenicity (Oct 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:15134283
- GRCh38:
- Chr17:15230966
| PMP22 | L145fs | Charcot-Marie-Tooth disease, type I, Inborn genetic diseases, not provided, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type IA | Pathogenic/Likely pathogenic (Sep 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276252
- GRCh38:
- Chr1:161306462
| MPZ | P151T | Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome, Dejerine-Sottas disease, not provided
| Conflicting interpretations of pathogenicity (Sep 2, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:15142922
- GRCh38:
- Chr17:15239605
| PMP22 | L62R | Guillain-Barre syndrome, familial, Hereditary liability to pressure palsies, Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease, type IA, Roussy-Lévy syndrome, Dejerine-Sottas disease, Charcot-Marie-Tooth disease, type I, not specified, not provided
| Uncertain significance (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161275943
- GRCh38:
- Chr1:161306153
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B, not specified, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161275729
- GRCh38:
- Chr1:161305939
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome, not provided, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease, not specified
| Benign/Likely benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161284226-161284227
- GRCh38:
- Chr1:161314434-161314435
| MPZ, SDHC | | Charcot-Marie-Tooth, Intermediate, Gastrointestinal stroma tumor, Paragangliomas 3, Hereditary cancer-predisposing syndrome, Charcot-Marie-Tooth disease, type I, not specified, not provided, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome, Pheochromocytoma | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161277096
- GRCh38:
- Chr1:161307306
| MPZ | I62M | Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2I, Roussy-Lévy syndrome
| Conflicting interpretations of pathogenicity (Mar 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161276512
- GRCh38:
- Chr1:161306722
| MPZ | Y145S | MPZ-related condition, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 2I, Dejerine-Sottas disease, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease, type I, not provided | Pathogenic (Mar 29, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276553
- GRCh38:
- Chr1:161306763
| MPZ | N131K | Charcot-Marie-Tooth disease, type I, not provided | Pathogenic (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276575
- GRCh38:
- Chr1:161306785
| MPZ | T124M | Inborn genetic diseases, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 2I, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease, type I, not provided, Charcot-Marie-Tooth disease dominant intermediate D ...see more | Pathogenic (Jul 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276204
- GRCh38:
- Chr1:161306414
| MPZ | G167R | Charcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type I | Pathogenic (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:15164009
- GRCh38:
- Chr17:15260692
| PMP22 | H12Q | Inborn genetic diseases, Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome
| Pathogenic/Likely pathogenic (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| | PMP22 | | Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type IA | Pathogenic (Oct 18, 2012) | no assertion criteria provided |